Swedish Orphan Biovitrum AB (publ) provided revenue guidance for the year 2024. For the period, the company anticipated revenue to grow by a high single-digit percentage at CER.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
285.4 SEK | +0.71% | +8.60% | +6.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.89% | 8.83B | |
-3.81% | 86.85B | |
+2.76% | 40.16B | |
-16.48% | 31.28B | |
+57.86% | 25.27B | |
-13.58% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
-6.43% | 7.94B | |
+1.55% | 7.58B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024